Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Knauer

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Trials|December 6, 2018
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trialGuido Henke, Michael Knauer, Karin Ribi, et al.
Journal of the American Chemical Society|September 23, 2009
Mimics of the self-assembling chlorosomal bacteriochlorophylls: regio- and stereoselective synthesis and stereoanalysis of acyl(1-hydroxyalkyl)porphyrinsTeodor Silviu Balaban, Anil Dnyanoba Bhise, Gerhard Bringmann, et al.
Breast Cancer Research : BCR|December 15, 2021
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-RegistrySimon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon, et al.
Eclinicalmedicine|December 2, 2022
Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancerToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2025
Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Michael Knauer, Daniel Egle, Stefanie Hayoz, et al.
Clinical Chemistry and Laboratory Medicine|May 26, 2025
Recommendations for the integration of standardized quality indicators for glucose point-of-care testingJulie L V Shaw, Saranya Arnoldo, Ihssan Bouhtiany, et al.
The Lancet. Oncology|September 10, 2018
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trialViviana Galimberti, Bernard F Cole, Giuseppe Viale, et al.
Breast Cancer Research and Treatment|December 4, 2018
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)Christoph J Rageth, Elizabeth A M O'Flynn, Katja Pinker, et al.
Breast Cancer Research and Treatment|June 2, 2019
Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)Christoph J Rageth, Elizabeth A M O'Flynn, Katja Pinker, et al.
The New England Journal of Medicine|December 12, 2024
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA TrialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Trials|December 6, 2018
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trialGuido Henke, Michael Knauer, Karin Ribi, et al.
Journal of the American Chemical Society|September 23, 2009
Mimics of the self-assembling chlorosomal bacteriochlorophylls: regio- and stereoselective synthesis and stereoanalysis of acyl(1-hydroxyalkyl)porphyrinsTeodor Silviu Balaban, Anil Dnyanoba Bhise, Gerhard Bringmann, et al.
Breast Cancer Research : BCR|December 15, 2021
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-RegistrySimon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon, et al.
Eclinicalmedicine|December 2, 2022
Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancerToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2025
Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Michael Knauer, Daniel Egle, Stefanie Hayoz, et al.
Clinical Chemistry and Laboratory Medicine|May 26, 2025
Recommendations for the integration of standardized quality indicators for glucose point-of-care testingJulie L V Shaw, Saranya Arnoldo, Ihssan Bouhtiany, et al.
The Lancet. Oncology|September 10, 2018
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trialViviana Galimberti, Bernard F Cole, Giuseppe Viale, et al.
Breast Cancer Research and Treatment|December 4, 2018
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)Christoph J Rageth, Elizabeth A M O'Flynn, Katja Pinker, et al.
Breast Cancer Research and Treatment|June 2, 2019
Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)Christoph J Rageth, Elizabeth A M O'Flynn, Katja Pinker, et al.
The New England Journal of Medicine|December 12, 2024
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA TrialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Pageof 7